Niagen Bioscience (NAGE) Inventory Average (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Inventory Average data on file, last reported at $22.2 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $22.2 million, up 118.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.2 million (up 118.09% YoY), and the FY2025 annual result was $14.8 million, up 24.87% from the prior year.
• Inventory Average grew to $22.2 million in Q1 2026 per NAGE's latest filing, from $19.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $22.2 million in Q1 2026 and troughed at $9.9 million in Q4 2024.
• A 5-year average of $14.1 million and a median of $13.5 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2024 and 2026: Inventory Average slipped 27.3% in 2024, then surged 118.09% in 2026.
• A 5-year view of Inventory Average shows it stood at $15.2 million in 2022, then decreased by 10.44% to $13.6 million in 2023, then fell by 27.3% to $9.9 million in 2024, then surged by 98.7% to $19.6 million in 2025, then increased by 13.32% to $22.2 million in 2026.
• Business Quant data shows NAGE's Inventory Average at $22.2 million in Q1 2026, $19.6 million in Q4 2025, and $16.6 million in Q3 2025.